IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Aakaar Medical Technologies IPO is a book build IPO listing on NSE EMERGE exchange. The company is based in Mumbai and caters to Cosmetic sector. Indorient Financial Services is the merchant banker of Aakaar Medical Technologies IPO. It is a SME UPCOMING IPO which filed its Draft Red Herring Prospectus (DRHP) on 28th February 2025.
Aakaar Medical Technologies IPO posted revenues of Rs 51.31 crores and PAT of Rs -1.01 crores in FY25 on annualised basis.Financial results of Aakaar Medical Technologies IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Aakaar Medical Technologies IPO PAT Margin is -1.92%, ROCE (Return on Capital Employed) is 0.39% as per latest financial. The below table shows Aakaar Medical Technologies IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
The market Capitalisation of Aakaar Medical Technologies IPO is Rs [●] crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Aakaar Medical Technologies IPO prospectus highlights an Return on Equity (ROE) of 15%, Return on Assets (ROA) of 12%, and an EBITDA Margin of 18%, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Aakaar Medical Technologies IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Aakaar Medical Technologies IPO is ₹[●] Cr, based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Aakaar Medical Technologies IPO has a Price-to-Earnings (PE) ratio of [●], indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Aakaar Medical Technologies IPO reported revenue of ₹51.31 Cr in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Aakaar Medical Technologies IPO provide insights into sales growth, market demand, and business scalability.
Aakaar Medical Technologies recorded an EBITDA of ₹ 0.26 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Aakaar Medical Technologies Profit After Tax (PAT) is ₹-0.98 Cr, reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Revenue:
₹ 51.22 Cr.
EBITDA Margin:
0.52
%
Net Worth: ₹ 12.40 Cr.
Market Capitalisation:
[●]
P/E:
[●]
P/BV: [●]
EV/EBITDA: [●]
Aakaar Medical Technologies operates in Cosmetic and . The Issue is listed on NSE EMERGE in Apr, 2025. Aakaar Medical Technologies IPO size was with Issue price of .
Merchant Banker(s) of Aakaar Medical Technologies IPO: Indorient Financial Services Limited
Aakaar Medical Technologies IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Aakaar Medical Technologies IPO listed at a listing price of against the offer price of .
The current market price of Aakaar Medical Technologies is .
Why Us?
